Prolactin, a potential biomarker for chronic GVHD activity.

María Queralt SalasShereen EzzatWilson LamArjun Datt LawIvan Pasic Fotios V Michelis Dennis Dong Hwan KimArmin GerbitzZeyad Al-ShaibaniAuro ViswabandyaRajat KumarJonas MattssonJeffrey Howard Lipton

Published in: European journal of haematology (2020)

Prolactin may serve as a biomarker for cGVHD activity. Further studies are required to confirm these findings, and to explore if hyperprolactinemia has an impact on cGVHD severity and prognosis.

Keyphrases

growth hormone
case control
drug induced